Position in ESPR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
New position
Shares Held
400,000
first reported quarter
Ownership
0.155%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Kintayl Capital LP holds $0 across 1 Drug Manufacturers - Specialty & Generic name. ESPR ranks #1 .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ESPR |
Esperion Therapeutics, Inc.
This page
|
400,000 | $0 |
All Filings in ESPR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 400,000 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||